Oxford University breakthrough on global COVID-19 vaccine
The NIHR Oxford Biomedical Research Centre is a collaboration between the University of Oxford and Oxford University Hospitals NHS Foundation Trust to fund medical research.
Latest News
Latest data on immune response to COVID-19 reinforces need for vaccinationIn Antimicrobial Resistance and Modernising Microbiology, COVID-19, Gastroenterology and Mucosal Immunity, Vaccines for Emerging and Endemic Diseases17 June 2021
Impaired antibody response to COVID-19 vaccination in patients with myeloid blood cancers17 June 2021
Oxford wins government funding to evaluate prostate cancer detection system16 June 2021
Treating needle fears may reduce COVID-19 vaccine hesitancy16 June 2021
We’re delighted to be one of the winners in Round 2 of the @AACinnovation @NHSX @NIHRresearch #AIAward, receiving funding for lung cancer prediction through the #NHSAILab. Find out more here: https://t.co/D74WDxlIOm #ArtificialIntelligence
Our preprint on immune responses following infection with #COVID19 is now available on @researchsquare! Many thanks to all the staff, participants and our funders that have made this important work possible.
https://t.co/CYnTKtd7iV
Our analysis of serological responses to COVID-19 vaccination in 60 patients with chronic myeloid neoplasms (CML, MPN and MDS) is now online @ British Journal of Haematology @WileyOnc_Hem https://t.co/hIVQLRioiE. @MPNVoice @MPN_Hub @MPN_RF 1/4
Some really important #COVID19 vaccine response findings that will help inform guidance to those who are more vulnerable #BloodCancer @bloodcancer_uk https://t.co/r5VOG2vh6g
Our Research Themes
Patient and Public Involvement
Recent Listings for Patients Active in Research
OPEN ARMS Project Oxford – Patient Partners
